132 related articles for article (PubMed ID: 38817040)
41. Cytogenetic findings in leukemic cells of 56 patients with constitutional chromosome abnormalities. A cooperative study. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1988 Oct; 35(2):243-52. PubMed ID: 2972356
[TBL] [Abstract][Full Text] [Related]
42. Chronic myelomonocytic leukemia: single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1991 Aug; 55(1):57-65. PubMed ID: 1913608
[TBL] [Abstract][Full Text] [Related]
43. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.
Gervais C; Murati A; Helias C; Struski S; Eischen A; Lippert E; Tigaud I; Penther D; Bastard C; Mugneret F; Poppe B; Speleman F; Talmant P; VanDen Akker J; Baranger L; Barin C; Luquet I; Nadal N; Nguyen-Khac F; Maarek O; Herens C; Sainty D; Flandrin G; Birnbaum D; Mozziconacci MJ; Lessard M;
Leukemia; 2008 Aug; 22(8):1567-75. PubMed ID: 18528428
[TBL] [Abstract][Full Text] [Related]
44. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies".
Grimwade D; Biondi A; Mozziconacci MJ; Hagemeijer A; Berger R; Neat M; Howe K; Dastugue N; Jansen J; Radford-Weiss I; Lo Coco F; Lessard M; Hernandez JM; Delabesse E; Head D; Liso V; Sainty D; Flandrin G; Solomon E; Birg F; Lafage-Pochitaloff M
Blood; 2000 Aug; 96(4):1297-308. PubMed ID: 10942371
[TBL] [Abstract][Full Text] [Related]
45. Abnormalities of the long arm of chromosome 21 in 107 patients with hematopoietic disorders: a collaborative retrospective study of the Groupe Français de Cytogénétique Hématologique.
Jeandidier E; Dastugue N; Mugneret F; Lafage-Pochitaloff M; Mozziconacci MJ; Herens C; Michaux L; Verellen-Dumoulin C; Talmant P; Cornillet-Lefebvre P; Luquet I; Charrin C; Barin C; Collonge-Rame MA; Pérot C; Van den Akker J; Grégoire MJ; Jonveaux P; Baranger L; Eclache-Saudreau V; Pagès MP; Cabrol C; Terré C; Berger R;
Cancer Genet Cytogenet; 2006 Apr; 166(1):1-11. PubMed ID: 16616106
[TBL] [Abstract][Full Text] [Related]
46. Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.
Nguyen-Khac F; Lesty C; Eclache V; Couronné L; Kosmider O; Andrieux J; Collonge-Rame MA; Penther D; Lafage M; Bilhou-Nabera C; Chapiro E; Mozziconacci MJ; Mugneret F; Gachard N; Nadal N; Lippert E; Struski S; Dastugue N; Cabrol C; Bernard OA;
Genes Chromosomes Cancer; 2010 Oct; 49(10):919-27. PubMed ID: 20629097
[TBL] [Abstract][Full Text] [Related]
47. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1988 Jun; 32(2):157-68. PubMed ID: 3163258
[TBL] [Abstract][Full Text] [Related]
48. Isochromosome 21q in hematologic malignancies. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1991 Aug; 55(1):101-5. PubMed ID: 1913595
[TBL] [Abstract][Full Text] [Related]
49. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique.
Blood; 1996 Apr; 87(8):3135-42. PubMed ID: 8605327
[TBL] [Abstract][Full Text] [Related]
50. Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: a cooperative study. Groupe Francais de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1984 Jun; 12(2):95-104. PubMed ID: 6722760
[TBL] [Abstract][Full Text] [Related]
51. Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia.
Alpatov R; Carstens B; Harding K; Jarrett C; Balakhani S; Lincoln J; Brzeskiewicz P; Guo Y; Ohene-Mobley A; LeRoux J; McDaniel V; Meltesen L; Minka D; Patel M; Manavi C; Swisshelm K
Mol Cytogenet; 2015; 8():101. PubMed ID: 26719766
[TBL] [Abstract][Full Text] [Related]
52. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders.
Michaux L; Mecucci C; Stul M; Wlodarska I; Hernandez JM; Meeus P; Michaux JL; Scheiff JM; Noël H; Louwagie A; Criel A; Boogaerts M; Van Orshoven A; Cassiman JJ; Van Den Berghe H
Genes Chromosomes Cancer; 1996 Jan; 15(1):38-47. PubMed ID: 8824724
[TBL] [Abstract][Full Text] [Related]
53. Cytogenetics of chronic myelomonocytic leukemia.
Cancer Genet Cytogenet; 1986 Mar; 21(1):11-30. PubMed ID: 3455874
[TBL] [Abstract][Full Text] [Related]
54. Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
Lazarian G; Munger M; Quinquenel A; Dilhuydy MS; Veronese L; Luque Paz D; Guièze R; Ledoux-Pilon A; Paillassa J; Merabet F; Vial JP; Bidet A; Waultier Rascalou A; Broseus J; Roos-Weil D; Lavaud A; Molina L; Laribi K; Hivert B; Friedrich C; Carpentier B; Ysebaert L; Van Den Neste E; Willems L; Corby A; Poulain S; Eclache V; Maubec E; Martin A; Feugier P; Delmer A; Baran-Marszak F; Leprêtre S; Cymbalista F
Am J Hematol; 2021 Sep; 96(9):E353-E356. PubMed ID: 34152612
[No Abstract] [Full Text] [Related]
55. French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique.
Cancer; 1987 Sep; 60(6):1385-94. PubMed ID: 3476180
[TBL] [Abstract][Full Text] [Related]
56. Forty-four cases of childhood myelodysplasia with cytogenetics, documented by the Groupe Français de Cytogénétique Hématologique.
Leukemia; 1997 Sep; 11(9):1478-85. PubMed ID: 9305601
[TBL] [Abstract][Full Text] [Related]
57. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases.
Michaux L; Dierlamm J; Wlodarska I; Bours V; Van den Berghe H; Hagemeijer A
Cancer Genet Cytogenet; 1997 Mar; 94(1):36-43. PubMed ID: 9078289
[TBL] [Abstract][Full Text] [Related]
58. Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).
Godet S; Protin C; Dupuis J; Dartigeas C; Bastie JN; Herbaux C; Leblond V; de Guibert S; Ghez D; Brion A; Ysebaert L; Delmer A; Quinquenel A
Am J Hematol; 2018 Feb; 93(2):E52-E54. PubMed ID: 29164674
[No Abstract] [Full Text] [Related]
59. Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
Laribi K; Poulain S; Willems L; Merabet F; Le Calloch R; Eveillard JR; Herbaux C; Roos-Weil D; Chaoui D; Roussel X; Tricot S; Dupuis J; Dartigeas C; Bareau B; Bene MC; Baugier de Materre A; Leblond V
Br J Haematol; 2019 Jul; 186(1):146-149. PubMed ID: 30548257
[No Abstract] [Full Text] [Related]
60. Cytogenetics might elucidate the etiology of acute transformation of chronic myeloproliferative syndromes without a Philadelphia chromosome. A brief report from a multicenter study by the Group Français de Cytogénétique Hématologique.
Eur J Haematol; 1989 Jul; 43(1):86-7. PubMed ID: 2670606
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
